WAT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

383.520

Open

380.000

VWAP

377.57

Vol

806.67K

Mkt Cap

36.81B

Low

374.270

Amount

304.58M

EV/EBITDA(TTM)

39.58

Total Shares

98.19M

41.95B

EV/OCF(TTM)

107.58

P/S(TTM)

6.56

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.

Events Timeline

(ET)

2026-06-24

09:01:00

IMU Biosciences Partners with Waters Corporation for AI Immunology Platform

2026-06-24

09:00:00

Waters and IMU Biosciences Form Strategic Partnership

2026-06-03 (ET)

2026-06-03

08:10:00

Waters BD BACTEC FXI System Receives FDA 510(k) Clearance

News

9.5

07-02PRnewswire

Waters Corporation to Hold Q2 2026 Earnings Call on August 4

9.5

07-02Newsfilter

Waters Corporation to Hold Q2 2026 Financial Results Conference Call on August 4

9.5

07-02Yahoo Finance

Waters Corporation Schedules Q2 2026 Earnings Conference Call

7.5

06-24NASDAQ.COM

Waters and IMU Bioscience Form Strategic Partnership

5.0

06-09PRnewswire

Waters Launches Innovative Battery Safety Testing Instrument

5.0

06-08PRnewswire

Waters Launches Innovative BioResolve and GTxResolve Columns for Biopharmaceuticals

13 Analyst Rating

Wall Street analysts forecast WAT stock price to rise

8 Buy

5 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

350.00

Averages

414.08

High

480.00

Current: 0.000

Low

350.00

Averages

414.08

High

480.00

Evercore ISI

NULL

Outperform

maintain

$380 -> $410

AI Analysis

2026-07-06

New

Reason

Evercore ISI

Price Target

$380 -> $410

AI Analysis

2026-07-06

New

maintain

NULL

Outperform

Reason

Evercore ISI raised the firm's price target on Waters to $410 from $380 and keeps an Outperform rating on the shares. The firm's Q2 preview for MedTech, Life Sciences Tools, and Diagnostics highlights generally healthy procedure volumes and capital expenditure trends across the sector, the analyst tells investors in a research note.

Bernstein

Eve Burstein

resume

$435

2026-06-26

Reason

Bernstein

Eve Burstein

Price Target

$435

2026-06-26

resume

Reason

Bernstein analyst Eve Burstein resumed coverage of Waters with an Outperform rating and $435 price target following a return from maternity leave. \"Many things\" are going right for the life science tools and diagnostics sector, the analyst tells investors in a research note. The firm says new drug approvals, trial starts, and funding are all better in the last 12 months versus the 12 months prior. Bernstein believes funding will start translating into customer spend while re-shoring will drive incremental investment at a time when AI-driven demand for semiconductor-related tools will continue to grow.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for WAT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Waters Corp (WAT.N) is 26.11, compared to its 5-year average forward P/E of 26.24. For a more detailed relative valuation and DCF analysis to assess Waters Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

26.24

Current PE

26.11

Overvalued PE

30.26

Undervalued PE

22.22

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

20.68

Current EV/EBITDA

74.78

Overvalued EV/EBITDA

30.47

Undervalued EV/EBITDA

10.89

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

6.28

Current PS

5.23

Overvalued PS

7.39

Undervalued PS

5.17

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

us stock market

Intellectia · 55 candidates

Relative Vol: >= 1.20Moving Average Relationship: PriceAboveMA20, PriceAboveMA5Is Optionable: TrueIs Index Component: GSPC, NDX, DJIOne Day Predict Return: >= 0.0%One Week Predict Return: >= 0.0%Macd: bullish, positive

Ticker

Name

Market Cap$

NTAP

NetApp Inc

34.39B

TEAM

Atlassian Corp

27.31B

NOW

ServiceNow Inc

128.26B

IBM

International Business Machines Corp

279.90B

WDAY

Workday Inc

36.11B

PANW

Palo Alto Networks Inc

229.86B

give me best stocks to night trade tonight

Intellectia · 84 candidates

Market Cap: >= 500.00MVolume: >= 500,000Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceCrossAboveMA20Is Optionable: TrueMonthly Average Dollar Volume: >= 300,000News Driver: Positive

Ticker

Name

Market Cap$

EVER

EverQuote Inc

842.59M

STRL

Sterling Infrastructure Inc

24.73B

DOCN

DigitalOcean Holdings Inc

15.94B

VRDN

Viridian Therapeutics Inc

1.93B

BLDP

Ballard Power Systems Inc

1.31B

IART

Integra Lifesciences Holdings Corp

1.03B

buy or hold

Intellectia · 100 candidates

Price: >= $-100.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Ema 60: >= -100Macd: positiveNews Driver: Positive

Ticker

Name

Market Cap$

BDSX

Biodesix Inc

113.91M

CIFR

Cipher Digital Inc

7.26B

LIND

Lindblad Expeditions Holdings Inc

1.17B

IIPR

Innovative Industrial Properties Inc

1.51B

PLOW

Douglas Dynamics Inc

1.03B

WAT

Waters Corp

29.63B

highest return likely tomorrow

Intellectia · 67 candidates

Market Cap: >= 300.00MPrice: $2.00 - $500.00One Day Rise Prob: >= 55One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Planet Labs PBC

9.24B

BTSG

Brightspring Health Services Inc

8.09B

RDW

Redwire Corp

1.94B

So-Young International Inc

332.79M

SNCY

Sun Country Airlines Holdings Inc

874.99M

CLS

Celestica Inc

32.42B

which stock is going to skyrocket tomorrow

Intellectia · 41 candidates

Rsi Category: moderateRelative Vol: >= 1.20Analyst Action: UpgradeMoving Average Relationship: PriceCrossAboveMA20

Ticker

Name

Market Cap$

BMA

Banco Macro SA

6.27B

HRI

Herc Holdings Inc

5.48B

CINT

Ci&T Inc

608.04M

RNGR

Ranger Energy Services Inc

354.89M

RXRX

Recursion Pharmaceuticals Inc

2.40B

LTH

Life Time Group Holdings Inc

6.15B

Whales Holding WAT

Freemont Capital Pte. Ltd.

Champlain Investment Partners, LLC

BLI - Banque De Luxembourg Investments S.A.

Fundsmith Investment Services Limited

Trading Trends

People Also Watch

Frequently Asked Questions

What is Waters Corp (WAT) stock price today?

The current price of WAT is 374.93 USD — it has decreased -1.05

What is Waters Corp (WAT)'s business?

What is the price predicton of WAT Stock?

Wall Street analysts forecast WAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WAT is414.08 USD with a low forecast of 350.00 USD and a high forecast of 480.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.